Der Klinikarzt

LinksSchließen

Referenz

Hollebecque A, Meyer T, Moore KN. et al.
An open-label, multicohort, phase I/II study of nivolumab in patients with virus-associated tumors (CheckMate 358): Efficacy and safety in recurrent or metastatic (R/M) cervical, vaginal, and vulvar cancers.

J Clin Oncol 2017;
35 (15_suppl) 5504-5504

Bibliographische Angaben herunterladen

Suchen in:

Aufrufen in: